Alkermes reports nine-month narcolepsy drug trial results

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Shein eyes up to $3 billion Hong Kong IPO as soon as August, Bloomberg News reports Hisse Senetleri 0 1
A TD Cowen raises Alkermes stock price target to $57 on drug data Hisse Senetleri 0 1
A Person killed in ICE-involved shooting in Maine, media reports Hisse Senetleri 0 1
A Virtus Investment Partners reports $152.2 billion in AUM Hisse Senetleri 0 1
A JPMorgan resumes Alkermes stock coverage with neutral rating Hisse Senetleri 0 2
A Form 144 Alkermes plc. For: 13 June Hisse Senetleri 0 10
A Form DEF 14A ALKERMES PLC For: 6 April Hisse Senetleri 0 41
A Alkermes stock price target raised to $47 from $46 at UBS on Avadel deal Hisse Senetleri 0 34

Benzer konular

Üst